Navigation Links
Techne Corporation Declares Dividend
Date:5/3/2011

MINNEAPOLIS, May 3, 2011 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.27 per share for the quarter ended March 31, 2011.  The quarterly dividend will be payable May 27, 2011 to all common shareholders of record on May 13, 2011.  Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Techne Corporation has two operating subsidiaries:  Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota, and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England.  R&D Systems is a specialty manufacturer of biological products.  R&D Systems has three subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California, Boston Biochem, Inc. (Boston Biochem) located in Cambridge, Massachusetts, and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China.  BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits.  Boston Biochem is a leading developer of ubiquitin-related research products.  R&D China and R&D Europe distribute biotechnology products.


'/>"/>
SOURCE Techne Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Techne Corporation Announces Acquisition
2. Techne Corporation Announces Acquisition
3. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
4. Techne Corporation Announces That Dr. Roeland Nusse Has Accepted a Seat on Its Board of Directors
5. Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010
6. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
7. Techne Corporation Declares Dividend
8. TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
9. Techne Corporation Board Member Recognized
10. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
11. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 16, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) ... quarter results on Thursday, April 30, 2015 at 4:00 ... will host a conference call at 4:30 PM Eastern ... company’s outlook for the future. , The conference call ... the homepage and in the Investor Relations section of ...
(Date:4/16/2015)... April 16, 2015 According to ... involving an outside source was ranked first among ... injuries related to lifting, pushing, pulling, holding, carrying, ... direct costs. The David Round Company takes statistics ... to working hard to develop and design equipment ...
(Date:4/16/2015)... , April 16, 2015  RegeneRx Biopharmaceuticals, Inc. ... its U.S. joint venture with G-treeBNT (ReGenTree LLC) ... 3 clinical trial for the orphan disorder, neurotrophic ... for dry eye syndrome (DES) in the U.S.  ... drops, RGN-259/GBT201, this year.  Each of these eye ...
(Date:4/16/2015)... BURLINGAME, Calif. , April 16, 2015  Scientists ... session, "New Drugs on the Horizon," at the American ... Philadelphia, PA on Sunday, April 19, ... , Ph.D., Cleave,s Director of Biology, will present new ... CB-5083, a first-in-class, oral inhibitor of p97, a critical ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3
... MUMBAI, India, Aug. 25 ,Codexis, Inc., a ... a leading Indian active pharmaceutical ingredients (APIs) ... strategic,collaboration, expanding their three-year partnership in pharmaceuticals,manufacturing., ... will offer multiple pharmaceutical,intermediates and active pharmaceutical ...
... DETROIT, Aug. 25 For the first time in ... highly sophisticated,3D robotics through a single incision., "We ... us to,perform this type of procedure routinely," says Craig ... performed the delicate,operation last week using the da Vinci ...
... Vice President of Commercial Operations,and James Briggs Senior ... Aug. 25 Ikaria Holdings, Inc., a fully,integrated ... two key executives. Stephen A. Ross was appointed ... was named Senior Vice,President for Human Relations., ...
Cached Biology Technology:Codexis, Arch Announce Expanded Collaboration 2Codexis, Arch Announce Expanded Collaboration 3State's First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital 2Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership 2
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... the "Global Iris Recognition Market 2015-2019" report ... Global Iris Recognition market to grow at a CAGR ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... 23, 2015  In the 2014 fiscal year, irs.gov ... losses. This figure accounts for a fraction of the ... Nilson Report, exceeds $11 billion globally. The polygraph has ... crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test in ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... lab tests of "killer paper," a material intended for ... preserve foods by fighting the bacteria that cause spoilage. ... contains a coating of silver nanoparticles, which are powerful ... that silver already finds wide use as a bacteria ...
... Basque Institute for Agricultural Research and Development) have ... of infection by visna/maedi virus. This is a ... pneumonia, mastitis and neurological disorders. The study confirmed ... of the virus is the most likely path ...
... apple growers in the northeastern United States are faced ... tree nutrition and crop load. These and other problems ... (IFP) and organic fruit production (OFP) of apples, limiting ... recent issue of HortScience , Cornell University scientists ...
Cached Biology News:Neiker-Tecnalia makes progress in detection and prevention of infection by visna maedi virus 2Neiker-Tecnalia makes progress in detection and prevention of infection by visna maedi virus 3Integrated, organic production systems evaluated for 'liberty' apple 2
Normal serum collected from healthy Kunming mice....
Request Info...
... involves the optimization of immunostaining. ... of the primary antibody, selection ... (e.g. Alk. Phos., HRP, fluorescence, ... detection, evaluation by light or ...
Ultra-sensitive, non-radioactive detection of Protein G. Measure Protein G levels quickly and easily....
Biology Products: